Evidence map›Paper›PMID 39222250›Full record

ArticleDiscover oncology2024

Hsa_circ_ROBO1 competes with miR-324-3p and upregulates NME1 to promote tumor metastasis in nasopharyngeal carcinoma.

FenFeng Liang, Hai Zhao, GengChun Liu, MeiLing Huang, ZhengJia Peng

Abstract read
In one paragraph

Article in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

FenFeng LiangDepartment of Otolaryngology and Head Surgery, Xiangtan Central Hospital, Xiangtan, 411100, Hunan, China.
Hai ZhaoDepartment of Otolaryngology and Head Surgery, Xiangtan Central Hospital, Xiangtan, 411100, Hunan, China.
GengChun LiuDepartment of Radiotherapy, Xiangtan Central Hospital, No.120, Heping Road, Yuhu District, Xiangtan, 411100, Hunan, China.
MeiLing HuangDepartment of Otolaryngology and Head Surgery, Xiangtan Central Hospital, Xiangtan, 411100, Hunan, China.
ZhengJia PengDepartment of Otolaryngology and Head Surgery, Xiangtan Central Hospital, Xiangtan, 411100, Hunan, China. pzjmdo3211@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis work aims to explore circ_ROBO1's function in nasopharyngeal carcinoma (NPC).

methodscirc_ROBO1 expression in NPC tissues and cell lines was measured. The regulation of circ_ROBO1 and/or miR-324-3p on the proliferation, migration, invasion, and apoptosis of NPC cells was investigated by functional experiments. The interplay between circ_ROBO1, miR-324-3p, and NME1 was explored. Tumor growth and metastasis were studied in mice.

resultscirc_ROBO1 was overexpressed in NPC. Knockdown of circ_ROBO1 repressed proliferation, migration, and invasion and induced apoptosis of NPC cells. Loss of circ_ROBO1 reduced tumor growth and metastasis in mice. circ_ROBO1 competed with miR-324-3p to upregulate NME1. Lowering miR-324-3p expression impaired the effect of knockdown of circ_ROBO1on NPC cells.

conclusionOverexpressed circ_ROBO1 promotes NPC development by modifying the miR-324-3p/NME1 axis.

Indexed as

Circ_ROBO1MetastasismiR-324-3pNasopharyngeal carcinomaNME1

Identifiers

PMID39222250
PMCPMC11369130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.